Last month, Novo Nordisk was the second most net-sold stock, but in February it has climbed to the top of the buy list.
"The company has delivered bad news in rapid succession, and investors seem to be caught in an unstoppable swing between hope and despair. Now that the share price has dropped by more than 40 percent in the past month and shareholders are buying in, it looks like hope has the upper hand," says Felicia Schön, savings economist at Avanza.
Investors have also picked up other companies with battered share performances, such as Microsoft and Klarna.
On the sell side, raw materials players like Boliden, Lundin Gold, and SSAB are featured.
"This is probably primarily about broad profit-taking after an incredibly strong performance recently," Schön says.
| Most Bought | Most Sold |
| Handelsbanken | Volvo |
| Swedbank | Boliden |
| EQT | Lundin Gold |
| Novo Nordisk | SSAB |
| Microsoft | Nibe |
| Investor B | Saab |
| Klarna | Telia |
| Investor A | Evolution |
| Apotea | Astra Zeneca |
| Hexagon | Vizsla SilverCorp |
